NM_005198.5:c.315G>A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_ModerateBP6_ModerateBP7
The NM_005198.5(CHKB):c.315G>A(p.Leu105Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,592,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00015 ( 0 hom. )
Consequence
CHKB
NM_005198.5 synonymous
NM_005198.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.11
Publications
0 publications found
Genes affected
CHKB (HGNC:1938): (choline kinase beta) Choline kinase (CK) and ethanolamine kinase (EK) catalyze the phosphorylation of choline/ethanolamine to phosphocholine/phosphoethanolamine. This is the first enzyme in the biosynthesis of phosphatidylcholine/phosphatidylethanolamine in all animal cells. The highly purified CKs from mammalian sources and their recombinant gene products have been shown to have EK activity also, indicating that both activities reside on the same protein. The choline kinase-like protein encoded by CHKL belongs to the choline/ethanolamine kinase family; however, its exact function is not known. Read-through transcripts are expressed from this locus that include exons from the downstream CPT1B locus. [provided by RefSeq, Jun 2009]
CHKB-CPT1B (HGNC:41998): (CHKB-CPT1B readthrough (NMD candidate)) The genes CHKB and CPT1B are adjacent on chromosome 22 and read-through transcripts are expressed that include exons from both loci. The read-through transcripts are candidates for nonsense-mediated mRNA decay (NMD) and are unlikely to express proteins. [provided by RefSeq, Jun 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 22-50582267-C-T is Benign according to our data. Variant chr22-50582267-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 468472.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.11 with no splicing effect.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CHKB | NM_005198.5 | c.315G>A | p.Leu105Leu | synonymous_variant | Exon 2 of 11 | ENST00000406938.3 | NP_005189.2 | |
| CHKB-CPT1B | NR_027928.2 | n.533G>A | non_coding_transcript_exon_variant | Exon 2 of 30 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152206Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
16
AN:
152206
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000420 AC: 9AN: 214496 AF XY: 0.0000431 show subpopulations
GnomAD2 exomes
AF:
AC:
9
AN:
214496
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000149 AC: 214AN: 1440482Hom.: 0 Cov.: 32 AF XY: 0.000143 AC XY: 102AN XY: 714644 show subpopulations
GnomAD4 exome
AF:
AC:
214
AN:
1440482
Hom.:
Cov.:
32
AF XY:
AC XY:
102
AN XY:
714644
show subpopulations
African (AFR)
AF:
AC:
1
AN:
33146
American (AMR)
AF:
AC:
0
AN:
42032
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25648
East Asian (EAS)
AF:
AC:
0
AN:
38862
South Asian (SAS)
AF:
AC:
0
AN:
82622
European-Finnish (FIN)
AF:
AC:
0
AN:
50614
Middle Eastern (MID)
AF:
AC:
0
AN:
4218
European-Non Finnish (NFE)
AF:
AC:
195
AN:
1103848
Other (OTH)
AF:
AC:
18
AN:
59492
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000105 AC: 16AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74350 show subpopulations
GnomAD4 genome
AF:
AC:
16
AN:
152206
Hom.:
Cov.:
33
AF XY:
AC XY:
9
AN XY:
74350
show subpopulations
African (AFR)
AF:
AC:
1
AN:
41468
American (AMR)
AF:
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
15
AN:
68018
Other (OTH)
AF:
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Megaconial type congenital muscular dystrophy Benign:1
May 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.